University of Houston
163
25
28
90
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
3.1%
5 terminated/withdrawn out of 163 trials
94.7%
+8.2% vs industry average
4%
7 trials in Phase 3/4
32%
29 of 90 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (163)
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
Role: lead
Mobile Health and COVID-19
Role: lead
Manage Emotions to Reduce Aggression (MERA)
Role: collaborator
Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control
Role: collaborator
Hormones, Outcomes, and Pain Pathways in Exercise Study
Role: lead
Integrating Food Rx With Best Feeding Practices With EFNEP
Role: collaborator
Enhancing Smoking Cessation for African American People Everywhere
Role: lead
Smartphone-based Wearable Telerehabilitation
Role: lead
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Role: collaborator
PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise
Role: collaborator
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Role: collaborator
Dilated Versus Non-Dilated Wavefront Corrections for Patients With Down Syndrome
Role: collaborator
Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study
Role: lead
Oral N-acetylcysteine for Retinitis Pigmentosa
Role: collaborator
Increasing the Repertoire of Intermuscular Co-ordination Post Stroke Through EMG-Guided Human-Machine Interaction
Role: lead
Smart Olfaction App to Reduce Relapse
Role: lead
Revolutionizing Normative Re-education
Role: collaborator
Immunometabolism of Exercise
Role: lead
Evaluating Telementoring for CHW-centered Diabetes Initiatives
Role: collaborator
Shaping Habitual Impulses For a Tobacco-free Style
Role: lead